You are here

Vistin Pharma ASA : Invitation to presentation of Q4 2017 results



Oslo, 22 February 2018

Vistin Pharma ASA (OSE: VISTIN) will release its fourth quarter 2017 results on Tuesday 27 February 2018.

The results will be presented by Vistin Pharma's CEO Kjell-Erik Nordby and CFO Gunnar Manum at 08:30 CET at Carnegie AS, Fjordalleen 16, Oslo, Norway. The presentation will be held in Norwegian.
  
The quarterly report and the presentation material will be available on www.vistin.com/investors and www.newsweb.no, as well as on news wires.

Vistin Pharma welcomes all interested parties.

For further information, please contact:

Gunnar Manum
CFO
+47 95 17 91 90
gunnar.manum@vistin.com


This information is subject to the disclosure requirements pursuant to section 5-12 of the Norwegian Securities Trading Act.

Thursday, February 22, 2018 - 09:38

More Headlines

Conversely, Kids Who Need Drugs Go Untreated
May Reduce the Need for Open-Heart Surgery
NDEA, a Known Carcinogen, Discovered During FDA Testing
Cleared for Adults with Relapsed or Refractory Disease
Approved as Maintenance Treatment for Opioid Dependence
Says Company’s OxyContin Had “Significant Role” in Opioid Epidemic
Study Uses Experimental Software to Decode Variations in Mood
Mixup with Losartan Discovered in Bottles